Upstream information

CVE-2014-6721 at MITRE


The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obtain sensitive information via a crafted certificate.

SUSE information

Overall state of this security issue: Resolved

This issue is currently rated as having moderate severity.

CVSS v2 Scores
  National Vulnerability Database
Base Score 5.4
Vector AV:A/AC:M/Au:N/C:P/I:P/A:P
Access Vector Adjacent Network
Access Complexity Medium
Authentication None
Confidentiality Impact Partial
Integrity Impact Partial
Availability Impact Partial
SUSE Bugzilla entry: 898604 [RESOLVED / WONTFIX]

No SUSE Security Announcements cross referenced.

Status of this issue by product and package

Please note that this evaluation state might be work in progress, incomplete or outdated. Also information for service packs in the LTSS phase is only included for issues meeting the LTSS criteria. If in doubt, feel free to contact us for clarification. The updates are grouped by state of their lifecycle. SUSE product lifecycles are documented on the lifecycle page.

Product(s) Source package State
Products past their end of life and not receiving proactive updates anymore.
SLES for SAP Applications 11 SP3 bash Released
SUSE Linux Enterprise Server 11 SP3 bash Affected
SUSE Linux Enterprise Server 11 SP3 LTSS bash Released
SUSE Linux Enterprise Server 11 SP3-LTSS bash Affected

SUSE Timeline for this CVE

CVE page created: Fri Sep 26 15:18:18 2014
CVE page last modified: Tue Jan 17 14:35:26 2023